AlzeCure Pharma AB(DE:AC6)
€0.54+-0.00 (+5.84%)
DE:AC6
AlzeCure Pharma AB financials statements
€0.54
At close:+-0.00 (+5.84%)
AlzeCure Pharma AB (AC6) Ratios
3 Followers
AlzeCure Pharma AB Ratios
DE:AC6's free cash flow for Q1 2026 was kr-17.09M. For the 2026 fiscal year, DE:AC6's free cash flow was increased by kr0.00 and operating cash flow was kr-17.09M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.33 | 4.15 | 3.84 | 2.66 | 3.49 |
| Quick Ratio | 2.33 | 4.15 | 3.84 | 2.66 | 3.49 |
| Cash Ratio | 2.14 | 3.82 | 3.54 | 2.47 | 3.29 |
| Solvency Ratio | -1.78 | -4.24 | -4.46 | -5.36 | -6.09 |
| Operating Cash Flow Ratio | -1.47 | -4.26 | 0.37 | -9.65 | -5.57 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 28.84M | kr 25.96M | kr 23.38M | kr 17.15M | kr 31.53M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.79 | 1.32 | 1.35 | 1.17 | 1.38 |
| Debt Service Coverage Ratio | -176.27 | 0.00 | 0.00 | -13866.50 | -77206.00 |
| Interest Coverage Ratio | -180.85 | 0.00 | 0.00 | -14110.50 | -77926.00 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.94 | 0.88 | 0.77 | 0.46 | 0.54 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 99.96% | 100.00% | 100.00% | 99.64% | 100.00% |
| EBT Per EBIT | 96.56% | 96.65% | 97.14% | 99.64% | 99.81% |
| Return on Assets (ROA) | -80.71% | -102.32% | -116.14% | -79.11% | -170.40% |
| Return on Equity (ROE) | -144.75% | -134.56% | -156.33% | -92.65% | -235.89% |
| Return on Capital Employed (ROCE) | -139.15% | -139.22% | -160.94% | -93.32% | -236.33% |
| Return on Invested Capital (ROIC) | -139.15% | -139.22% | -160.94% | -92.98% | -236.33% |
| Return on Tangible Assets | -80.73% | -102.37% | -116.20% | -79.13% | -170.46% |
| Earnings Yield | -23.71% | -40.00% | -20.48% | -30.12% | -36.71% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.30 | 0.11 | 0.18 | 0.12 | 0.10 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -295.64 | -234.15 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1196.90 | -3344.80 | -2060.41 | -3103.73 | -3785.27 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | -1.23 | -1.56 |
| Days of Payables Outstanding | 1196.90 | 3344.80 | 2060.41 | 3102.50 | 3783.71 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | -1.23 | -1.56 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.34 | -0.46 | 0.05 | -2.09 | -1.80 |
| Free Cash Flow Per Share | -0.34 | -0.46 | 0.05 | -2.09 | -1.80 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -283.25 | 0.00 | 0.00 | -1308.13 |
| Capital Expenditure Coverage Ratio | 0.00 | -283.25 | 0.00 | 0.00 | -1308.13 |
| Operating Cash Flow Coverage Ratio | -6.76 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -17.21% | -40.02% | 1.68% | -53.71% | -33.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.26 | -2.50 | -4.88 | -3.32 | -2.72 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 6.11 | 3.36 | 7.63 | 3.08 | 6.43 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.81 | -2.50 | 59.37 | -1.86 | -3.00 |
| Price-to-Operating Cash Flow Ratio | -5.81 | -2.51 | 59.37 | -1.86 | -3.00 |
| Price-to-Earnings Growth (PEG) Ratio | -1.96 | 0.11 | 0.10 | 0.08 | -0.31 |
| Enterprise Value Multiple | -3.24 | -1.59 | -4.02 | -2.88 | -2.20 |
| Enterprise Value | 155.78M | 56.59M | 152.40M | 160.44M | 170.17M |
| EV to EBITDA | -3.24 | -1.59 | -4.02 | -2.88 | -2.20 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -4.50 | -1.61 | 49.85 | -1.61 | -2.41 |
| EV to Operating Cash Flow | -4.50 | -1.61 | 49.85 | -1.61 | -2.41 |
| Tangible Book Value Per Share | 0.33 | 0.34 | 0.38 | 1.27 | 0.84 |
| Shareholders’ Equity Per Share | 0.33 | 0.34 | 0.38 | 1.27 | 0.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.47 | -0.46 | -0.60 | -1.17 | -1.98 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.97 | 0.98 | 0.97 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.73 | 1.00 | -0.08 | 1.77 | 0.91 |
Currency in SEK
